Primary aldosteronism

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Complications

By Mayo Clinic staff

Primary aldosteronism can lead to high blood pressure and low potassium levels. These complications in turn can lead to other problems.

Problems related to high blood pressure
Persistently elevated blood pressure can lead to problems with your heart and kidneys, including:

  • Heart attack
  • Heart failure
  • Left ventricular hypertrophy — enlargement of the muscle that makes up the wall of the left ventricle, your heart's main pumping chamber
  • Stroke
  • Kidney disease or kidney failure
  • Premature death

High blood pressure caused by primary aldosteronism carries a higher risk of cardiovascular complications than do other types of high blood pressure. This excess risk is due to the high aldosterone levels, which can cause heart and blood vessel damage independently of complications related to high blood pressure.

Problems related to low potassium levels
Some, but not all, people with primary aldosteronism have low potassium levels (hypokalemia). Mild hypokalemia may not cause any symptoms, but very low levels of potassium can lead to:

  • Weakness
  • Cardiac arrhythmias
  • Muscle cramps
  • Excess thirst or urination
References
  1. Funder JW, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2008;93:3266.
  2. Young WF, et al. Clinical features of primary aldosteronism. http://www.uptodate.com/home/index.html. Accessed Oct. 25, 2010.
  3. Primary aldosteronism. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec12/ch153/ch153f.html. Accessed Oct. 25, 2010.
  4. Sechi LA, et al. Cardiovascular and renal damage in primary aldosteronism: Outcomes after treatment. American Journal of Hypertension. In press. Acessed Oct. 25, 2010.
  5. Giacchetti G, et al. Management of primary aldosteronism: Its complications and outcomes after treatment. Current Vascular Pharmacology. 2009;7:244.
  6. Young WF, et al. Treatment of primary aldosteronism. http://www.uptodate.com/home/index.html. Accessed Oct. 25, 2010.
  7. Aldosterone and renin. Lab Tests Online. http://www.labtestsonline.org/understanding/analytes/aldosterone/test.html. Accessed Oct. 25, 2010.
  8. High blood pressure. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/dci/Diseases/Hbp/HBP_All.html. Accessed Oct. 25, 2010.
  9. High blood pressure, factors that contribute to. American Heart Association. http://www.americanheart.org/presenter.jhtml?identifier=4650. Accessed Oct. 25, 2010.
  10. Young WF, et al. Approach to the patient with hypertension and hypokalemia. http://www.uptodate.com/home/index.html. Accessed Oct. 25, 2010.
  11. Rose BD. Clinical manifestations and treatment of hypokalemia. http://www.uptodate.com/home/index.html. Accessed Oct. 25, 2010.
  12. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Bethesda, Md.: National Heart, Lung, Blood Institute. http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm. Accessed Oct. 25, 2010.
  13. Nippoldt TB (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 27, 2010.
DS00563 Jan. 6, 2011

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger